Beneficial Microbes is a prominent academic journal published by Wageningen Academic Publishers, focusing on the rapidly evolving fields of microbiology and its implications in health and medicine. With an ISSN of 1876-2883 and categorized in the Q2 quartile for both microbiology and medical microbiology in 2023, this journal provides a platform for innovative research that explores the beneficial roles of microbes in various ecosystems, particularly in human health. The journal ranks impressively within the Scopus database, holding the 46th position in microbiology and the 38th in medical microbiology, showcasing its significant impact on the scientific community, with a 75th and 73rd percentile, respectively. Beneficial Microbes aims to foster interdisciplinary collaboration and advance knowledge through high-quality, peer-reviewed articles that emphasize rigorous research and practical applications. Researchers, professionals, and students alike are invited to engage with cutting-edge findings that could influence future developments in microbiological sciences and health interventions.

ANAEROBE is a highly regarded scholarly journal published by Elsevier Science Ltd, dedicated to advancing the study of anaerobic microorganisms and their roles in infectious diseases, microbiology, and various clinical applications. With an ISSN of 1075-9964 and an E-ISSN of 1095-8274, this journal has established itself as a pivotal resource for researchers and professionals interested in the unique aspects of anaerobic biology since its inception in 1995. Ranking in the Q2 category in both Infectious Diseases and Microbiology, it stands out for its commitment to publishing high-quality research that reflects the evolving complexities of microbial interactions in health and disease. Although the journal currently does not offer Open Access options, its impact is notable, with the 2023 Scopus rankings reflecting a practice of excellence—ranked #137/344 in Infectious Diseases and #96/182 in Microbiology. As a vital forum for scholarly exchange, ANAEROBE serves as an essential platform for scientists seeking to explore the depths of anaerobic studies, shaping future discoveries and clinical advancements.

Bioscience of Microbiota Food and Health, an esteemed journal published by BMFH PRESS, serves as a pivotal platform for interdisciplinary research in the expanding fields of applied microbiology, food science, and gastroenterology. Since its inception in 2014, the journal has facilitated a critical exchange of scientific knowledge, promoting advancements in our understanding of microbiota's role in human health and nutrition. With its impressive 2023 category quartile rankings—Q2 in Applied Microbiology and Biotechnology, Food Science, and Gastroenterology—it stands out among its peers, appealing to researchers, professionals, and students alike. The journal does not follow an open-access model, which underscores its exclusivity while maintaining rigorous peer-review standards. Based in Japan, it provides a global forum for innovative studies that advance the field and enhance public health outcomes. As the journal converges into its next decade, it continues to uphold its commitment to disseminating high-quality research that bridges the gap between microbiota, food, and human health.

AIMS Microbiology, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed Open Access journal dedicated to advancing the field of microbiology since its inception in 2015. With an ISSN of 2471-1888, the journal aims to disseminate high-quality research and innovative findings pertaining to both fundamental and applied microbiology, encompassing areas such as medical microbiology, immunology, and related life sciences. Recognized for its academic rigor, AIMS Microbiology has achieved a significant standing, evidenced by its current Q2 ranking in both Microbiology and Medical Microbiology categories, along with impressive percentile rankings within prestigious Scopus metrics. Based in the United States, the journal not only emphasizes accessibility and widespread dissemination of knowledge but also plays a crucial role in fostering collaboration among researchers and professionals in the microbiological sciences. By providing a platform for collaborative research and innovative ideas, AIMS Microbiology is poised to influence the future development and application of microbiological research, making it a valuable resource for students, researchers, and practitioners alike.

FOLIA MICROBIOLOGICA is a distinguished academic journal published by SPRINGER, focusing on the intricate realms of microbiology and its contributions to medicine. Since its inception in 1957, the journal has been a vital platform for disseminating pioneering research, addressing contemporary challenges in the field while facilitating discourse among researchers, clinicians, and students alike. With an ISSN of 0015-5632 and an E-ISSN of 1874-9356, FOLIA MICROBIOLOGICA publishes original articles, reviews, and critical insights that span not only traditional microbiological studies but also innovative applications in immunology and biotechnology. The journal is categorized within the esteemed Q2 tier in Medicine (Miscellaneous) and holds a Q3 rating in Microbiology as of 2023, reflecting its significant impact and relevance in the scientific community. Although it does not currently offer open access, it remains a respected resource, enabling professionals and students to keep abreast of advancements from its base in the Netherlands. With a strong commitment to quality and rigorous peer-review, FOLIA MICROBIOLOGICA serves as an essential repository of knowledge, fostering the next generation of microbiologists and medical practitioners.

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Infectious Microbes & Diseases, published by Lippincott Williams & Wilkins, is a premier journal dedicated to the exploration and understanding of infectious diseases, microbiology, and epidemiology. With its focused scope and robust peer-review process, the journal aims to disseminate high-quality research that contributes to advancements in the field, making it an essential resource for researchers, healthcare professionals, and students alike. Established in 2019, it has quickly gained recognition, achieving a Q3 rating in categories such as Epidemiology, Infectious Diseases, and Medical Microbiology in 2023, and ranking in the top half of its field within Scopus metrics. Although currently offered as a subscription-based journal, Infectious Microbes & Diseases significantly enriches its disciplines by inviting innovative research and critical review articles, thus playing a vital role in combating the global challenges posed by infectious diseases.

Gastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.